-
IntroducedJan 05, 2026
-
Passed Senate
-
Passed House
-
Became Law
Podiatric Medicine; Requiring certain podiatric physicians, instead of all podiatric physicians, to complete specified continuing education; authorizing podiatric physicians to perform stem cell therapy not approved by the United States Food and Drug Administration under certain circumstances; requiring podiatric physicians who perform such therapies to use stem cell therapy products obtained from facilities that adhere to applicable current good manufacturing practices, etc.
Summary
Comments on SB 1092
Tweets
Whip Lists
Sponsors
- Massulloprimary
Votes
Actions
- Jan 05, 2026 | Senate
- Filed
Bill Texts
Documents
